General Probiotics (GP) is a University of Minnesota start-up. GP develops advanced probiotics, a new antimicrobial technology for farmers to eliminate pathogens in livestock.

 

GP products will result in healthier animals, in higher productivity for farmers, and in safer food for consumers.  GP engineers are world leaders in probiotics, with the expertise to boost the natural capacity of probiotics to exterminate pathogens.

 

GP's advanced probiotics eliminate pathogens more effectively and reliably than any currently-marketed probiotic.  GP's technology is scientifically proven and is covered by three patent applications.

 

GP has been awarded Phase I and Phase II Small Business Innovative Research grants (a total of $825k), to pursue an unparalleled R&D program and to commercialize new antimicrobials.

GP was a 2017 MN cup Semifinalist.